Skip Navigation LinksHome > September 1990 - Volume 4 - Issue 9 > An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope.
Original papers: PDF Only

An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope.

Nixon, Douglas F.; Huet, Stephane; Rothbard, Jonathan; Kieny, Marie-Paule; Delchambre, Martine; Thiriart, Clotilde; Rizza, Charles R.; Gotch, Frances M.; McMichael, Andrew J.

Collapse Box


The HLA-B27-restricted HIV gag cytotoxic T-lymphocyte (CTL) epitope, 265-279, is highly conserved amongst HIV-1 isolates, only one, HIV-1ELI, having a single amino acid substitution. Over the same region HIV-2 differs by five amino acids. As a broadly cross-protective AIDS vaccine should protect against infection from all isolates of HIV-1 and HIV-2, we tested CTL specific for the HIV-1 265-279 epitope with peptide analogues from HIV-1ELI, HIV-2 and two simian immunodeficiency virus (SIV) isolates, and with recombinant vaccinia viruses expressing the respective gag genes, to determine whether there was any cross-reactivity for this CTL epitope. CTL from the HIV-1-infected donor could recognize the HIV-1ELI peptide, the HIV-2 peptide and recombinant vaccinia virus-infected target and one of the two SIV peptide-treated targets. Epitopes that exhibit such cross-reactivity may be valuable in vaccine design.

(C) Lippincott-Raven Publishers.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.